NCT01986673

Single-Dose Relative Bioavailability Study of SST-6006, a Topical Sildenafil Cream Versus Oral Sildenafil in Healthy Male Adults

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 62 (actual)
• Sponsor: Strategic Science & Technologies, LLC · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to evaluate how a single dose of sildenafil cream (SST-6006) is absorbed and eliminated by the body, with and without the use of a condom, compared to a single oral sildenafil dose and to evaluate the safety of sildenafil cream.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	5% Sildenafil Cream (SST-6006)	5 % Sildenafil Cream
DRUG	Oral Sildenafil 50 mg	Oral Sildenafil 50 mg

Timeline

• Start date: 2013-10-01
• Primary completion: 2013-11-01
• Completion: 2013-11-01
• First posted: 2013-11-18
• Last updated: 2014-01-27

Locations

1 site across 1 country: United States